Erschienen in:
21.08.2020 | Originalien
Short to mid-term outcome of total hip arthroplasty with cementless implants in patients younger than 25 years old
verfasst von:
Dr. Hirose Shakya, MD, MPH, Dr. Kai Zhou, Ph.D., Dr. Shun-Yu Yao, MD, Dr. Suraj Dahal, MD, Dr. Zong-Ke Zhou, Ph.D.
Erschienen in:
Die Orthopädie
|
Ausgabe 9/2021
Einloggen, um Zugang zu erhalten
Abstract
Background
Total hip arthroplasty (THA) was once reserved for old patients with hip arthritis but has become more common in very young patients (≤25 years old) diagnosed with various joint disease that were not relieved with conservative treatment. The purpose of this study was to evaluate short to mid-term outcome of THA in patients younger than 25 years old.
Method
This retrospective study included 45 patients younger than 25 years (mean age 21.8 ± 2.14 years) who underwent THA. The surgical indications, implant selection, leg length discrepancy, medication history, radiographic outcome, survival and clinical results including the modified Harris hip score (mHHS) and SF-36 score were assessed.
Result
The mean follow-up period recorded for patients was 7.82 years (range 5–12 years). The most common diagnosis was avascular necrosis (37.7%) followed by ankylosing spondylitis (24.4%), developmental dysplasia of the hip (17.7%) and rheumatoid arthritis (8.8%). The preoperative leg length discrepancy (LLD), which ranged from 0.5–7 cm significantly improved after surgery ranging from 0–1 cm. The mean preoperative mHHS was 32.44 ± 18.90 compared with the postoperative score of 94.54 ± 5.81 (p < 0.001). The preoperative p-value of SF-36 was lower compared to the postoperative value in all subgroups of SF-36 (p < 0.001). At the latest follow-up there were no radiological signs of loosening and all the implants were classified as well-integrated.
Conclusion
At present total hip arthroplasty is considered to be safe and a good solution for young patients below 25 years suffering from end-stage joint disease; however, longer follow-up is required to evaluate the long-term function and outcome of the prosthesis in order to restore the normal lifestyle of the patients.